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Abstract 
Background: Free radical production, changes in the proteome, and 
lipid peroxidation are the consequences of hyperglycemia in diabetes. 
This study aimed to examine the changes in plasma proteome along 
with oxidative status in type 2 diabetes.  
Methods: Thirty type 2 diabetic patients and 25 healthy subjects 
participated in this cross-sectional study. Fasting blood sugar, 
glycated hemoglobin (HbA1c), and lipid profile was measured in all 
subjects. To measure oxidative stress parameters, malondialdehyde 
(MDA) and total antioxidant capacity (TAC) were assayed. Plasma 
proteome pattern was determined using two-dimensional gel 
electrophoresis. Visual analysis of gels was performed using software 
(Image Master). 
Results: MDA level was higher in the diabetic group compared to the 
healthy group (4.10±0.57) vs. (3.2±0.10) nmol/ml, (Pvalue<0.01). TAC 
reduced in diabetic patients (17.85±1.2) vs. (38.60±2.4) mmol/ml, 
(Pvalue=0.01). Some changes were observed in the 2-D gel 
electrophoresis pattern in diabetic patients comparing to those of the 
healthy group. 
Conclusions: The results indicated the presence of oxidative stress in 
type 2 diabetes patients. Also, different proteome patterns showed the 
presence of different or modified proteins in diabetic patients that can 
be due to changes in the glycation of proteins or may be induced as a 
response to oxidative stress.  
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Introduction 
Diabetes is a chronic disease that gradually affects many 
different organs of the body. The disease progresses gradually 
and its symptoms occur several years after the onset of 
disease.1 
Diabetes is a treatable disease; however, when it is not 
under control the risk of serious and irreversible complications 
such as retinopathy, nephropathy, neuropathy, and vascular 
damages are expected.2 Moreover, physical inactivity is 
another risk factor for cardiovascular disease and insulin 
resistance. Although chronic hyperglycemia is an important 
factor in inducing complications of diabetes, the mechanisms 
that disrupt the organ’s function remains unknown.  
three main theories explain how hyperglycemia affects 
chronic complications in diabetes. One hypothesis is that 
increased intracellular glucose produces advanced glycation 
end-products (AGEs) through non-enzymatic glycosylation in 
cellular proteins. Non-enzymatic glycosylation is the result of 
glucose reaction with amine groups or proteins. The level of 
AGEs in serum levels is related to blood glucose concentration. 
On the other hand, the accumulation of these substances 
reduces the glomerular filtration rate. The second hypothesis in 
complications of diabetes is that hyperglycemia increases 
glucose metabolism through the sorbitol pathway.3 Most 
intracellular glucose metabolizes by glycolysis, but when the 
intracellular glucose increases, it is converted to sorbitol by 
aldose reductase. Increasing the concentration of sorbitol 
affects cellular physiology, causes cellular dysfunction and 
plays a role in the development of retinopathy, neuropathy, and 
nephropathy. Finally, the third hypothesis states that 
hyperglycemia increases the formation of diacylglycerol, which 
in turn activates protein kinases, affects a range of cellular 
events that cause complications of diabetes.3 
Humans spend the majority of their time in the postprandial 
state, which is hypothesized to be both pro-inflammatory and 
pro-oxidative. This may directly affect insulin resistance in 
skeletal muscle that contributes to the development of type 2 
diabetes.4 Furthermore, research has shown that T2DM is 
associated with inflammation, oxidative stress, and vascular 
dysfunction.5 
The production and accumulation of reactive oxygen 
species (ROS) and reactive nitrogen species (NRS) causes 
oxidative stress in the different tissues of the body, especially 
pancreatic beta cells.2,6  
Oxidative stress is caused by the imbalance between the 
production of free radicals and reactive oxygen species on the 
one hand and the antioxidant defense system on the other. In 
other words, in aerobic biologic systems, antioxidant defense 
mechanisms are designed to counteract free radicals and 
reactive oxygen species to neutralize or minimize the harmful 
effects of these invasive factors. Some components of this 
defense system, such as superoxide dismutase, glutathione 
peroxidase, and catalase enzymes, as well as, bilirubin and the 
molecules containing the thiol group are made inside the body, 
but others such as vitamin C, vitamin E, and beta-carotene 
should be supplied via diet. In oxidative stress, many 
macromolecules are damaged, and the process of oxidation of 
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proteins, lipid peroxidation (MDA), inactivation of enzymes, 
and malfunction of various membranes occur.7,8 
Assays for total antioxidant capacity (TAC) in plasma 
differ in their type of oxidation source, target and measurement 
used to detect the oxidized product.9 Glycated hemoglobin 
(HbA1c), is an indicator for overall glucose exposure 
integrating both fasting and postprandial hyperglycemia, even 
though their relative contribution is undefined.10 
The chronic hyperglycemia of diabetes is associated with 
long-term damage, dysfunction, and failure of various organs, 
especially the eyes, kidneys, nerves, heart, and blood vessels. 
Study the oxidative status along with alterations in plasma 
proteome pattern in diabetic patients can help know the 
mechanism of cellular and molecular dysfunction in this 
disease.   
By definition, all proteins expressed in a cell at a specific 
time are called the proteome. Since the proteome is expected to 
be different in T2M patients comparing to healthy people, 
studying these changes along with oxidative markers can be 
useful in the identification of molecular damages that are 
involved in diabetes complications.11  
The plasma proteome represents an important subproteome 
as it harbors proteins secreted from almost all tissues. This 
wide dynamic range of protein abundance makes plasma 
proteome a challenging proteome to analyze. Plasma proteins 
undergo various types of post-translational modifications such 
as glycosylation, which add to their complexity. Moreover, 
plasma protein glycation that occurs in diabetes may change 
the physicochemical properties of proteins that can affect the 
electrophoresis pattern of plasma.12 Hemoglobin (Hb) binds to 
four oxygen atoms, when Hb undergoes glycation its molecular 
weight increases; in this case, the oxygen supply is reduced, 
and instead of entering the cell, it moves out of the cell, and the 
risk of micro-vascularity increases.13 
According to the mentioned findings and with increasing 
glycated proteins, the proteome pattern in diabetic patients is 
expected to be different from those of healthy subjects. 
Therefore, this study aimed to determine the pattern of plasma 
proteome in type 2 diabetic patients and compared it with that 
of healthy subjects. Furthermore, oxidative stress indices 
(MDA and TAC) were measured and compared in these two 
groups; also, their correlation with glycemic control indices 
(HbA1c) was assayed and discussed.   
Materials and Methods  
Thirty type 2 diabetic patients participated in this study. 
The mean (age±SD) was (50±5) years and they had diabetes for 
8±2 years. The patients were selected from the referred 
individuals to Imam Hossein hospital laboratory (Shahrood, 
east of Iran). The patients were non-alcoholic and non-smoker. 
They did not have any other illnesses such as thyroid and 
autoimmune disorders and high blood pressure. They did not 
receive any other medication except blood glucose-lowering 
agents. Twenty-five healthy age and sex-matched subjects who 
were referred to the laboratory for checkups were selected as a 
control group. They had normal blood glucose and HbA1c. All 
participants gave informed consent and this study was 
approved by the ethics committee of the Islamic Azad 
university, Shahrood branch (Ethics ID: 
IR.IAU.SHAHROOD.REC.1399.019). 
Blood samples for preparing serum and plasma were 
collected after 10-12 hours of fasting. HbA1c, fasting blood 
sugar, and lipid profile were measured using an auto-analyzer 
and commercially available kits (Pars Azmun, Iran).   
Malondialdehyde as a marker for lipid peroxidation was 
measured using Buege and Aust method based on 
thiobarbituric acid reaction.12 Total antioxidant capacity was 
determined using Benezi et.al. method; it was based on the 
ferric reducing ability of plasma (FRAP).13 
Because of the high frequency of proteins present in the 
plasma, including albumin and gama-globulin, which make up 
about 80% of plasm proteins, their removal was essential. To 
remove albumin and gama-globulin, the Trichloroacetic 
acid/Acetone method was used.14,15 Total protein concentrations 
were measured using the Bradford protein assay kit. 
To study plasma proteome two-dimensional gel 
electrophoresis was used. Isoelectric focusing (IEF) that 
separates proteins due to differences in their isoelectric points 
(PI) was used as a first direction. 150 μg of total protein was 
loaded onto 17 cm nonlinear pH gradient (IPG) strips (pH 3-
10) and was allowed to be actively rehydrated for 12 hr at 50 V 
using protean IEF (Bio-Rad, USA). Rehydrated IPG strips, 
then, were focused according to the protocol until 50,000 Vh 
for 12 hr. For the second dimension, electrophoresis was 
performed using 12% SDS-poly acrylamide gels. Briefly, the 
equilibrated IPG strips were placed on top of an SDS-PAGE 
and sealed with agarose (0.5%, w/v). Gels were run in Tris-
glycine running buffer (pH 8.3) using POWER/PAC 3000 
(BioRad) at 100 V for 5 hr, and then at 150 V until the 
bromophenol blue dye reached the bottom of the gel. For 
colloidal Coomassie blue staining, the gels were rinsed 5 times 
with distilled water for 10 min; then they were stained with 
0.02%,w/v colloidal Coomassie solution containing G-250 
(5%, w/v), aluminum sulfate, ethanol (10%, v/v), 
orthophosphoric acid (2%, v/v) while rocking for 12 hr. High 
resolution according to protein size or weight (Mw) in the 
second direction was achieved by using SDS polyacrylamide 
gel electrophoresis (SDS-PAGE). Plasma proteome patterns in 
the 2D gels were recorded using an image Scanner III, Lab 
Scan 6 (Epson, Japan). Spots detection and image matching 
were performed with image Master Platinum 6.0. software.16-19 
The results were analyzed using SPSS (version 19). Normal 
distribution of data was examined and parametric and non-
parametric factors were compared between two groups using t-
test and Mann-Whitney U-Test, respectively. The correlation 
between obtained factors was assessed using Pearson test. The 
significant level was set at 0.05. 
Results 
Characteristics of demographic and biochemical parameters 
in diabetic and healthy subjects are shown in table 1. Among 
the common biochemical factors, glucose, total cholesterol, 
LDL-C in the diabetic patients showed a significant increase 
(Pvalue<0.01) compared to healthy subjects; while, HDL-C 
decreased significantly (Pvalue<0.01) in the diabetic group. 
Kheirodin et al 
 
   25       |        International Journal of Health Studies 2021;7(4)  
The total antioxidant capacity that was measured by the 
FRAP assay showed a significant reduction in diabetic patients 
(Pvalue<0.01). MDA level as an indicator of lipid peroxidation 
was higher in the diabetic group (Pvalue<0.01) compared to the 
healthy group (Table 1).   
Correlation between glucose and HbA1c with other factors 
was evaluated using the Pearson test and the results are shown 
in table 2. An increase in HbA1c in diabetic patients was 
directly related to an increase in MDA (r=0.90, Pvalue<0.01); 
moreover, there was a reverse relationship between HbA1c and 
TAC (r=-0.88, Pvalue<0.01). Moreover, there was a correlation 
between FBS and triglycerides and cholesterol (Pvalue=0.04) 
in diabetic patients. 
After the plasma specimen was separated using 2-D gel 
electrophoresis, visual analysis of gels was performed using 
software (Image Master) and the obtained pattern was 
compared between healthy and diabetic subjects. The pattern of 
2-D gel electrophoresis of plasma proteome in the diabetic 
group was different from that of healthy subjects (Figure 1). 
Figure 2 also shows the result of image analysis of serum 
proteins in healthy and diabetic groups. After examining the 
spots that indicated different proteins, it was found that the 
diabetic patient's pattern was different from that of the healthy 
subject in at least several spots. Comparing these images with a 
standard pattern of plasm proteins we identified some of these 
spots that are presented in table 3. Moreover, the results of the 
analysis of two spots (1529, 1550) are shown in Figure 3, 
indicating the difference in density of these proteins between 
diabetic and non-diabetic subjects. The first spot (1529) was 
identified as ApoA1 that showed an increase in diabetic 
subjects; the second one (1550) was Hp α2 chain that showed 
lower density in the diabetic subject. 
 
Table 1. Biochemical parameters of the studied groups 
Factor Healthy (n=25) Diabetic (n=30) Pvalue 
Age (year) 49.0±7.0 50.11±3.45 0.92 
BMI (Kg/m2) 24.90±0.73 26.31±1.33 0.001 
HbA1c (%) 4.78±0.58 10.37±1.94 0.001 
Glc (mg/dl) 111.68±11.18 237.68±65.75 0.001 
Cho (mg/dl) 191.96±40.49 186.07±40.05 0.001 
TG (mg/dl) 147.0±96.0 186.50±133.0 0.18 
LDL-C (mg/dl) 106.84±22.13 101.57±25.39 0.001 
HDL-C (mg/dl) 57.00±10.89 48.50±8.73 0.001 
MDA (nmol/ml) 3.23±0.09 4.13±0.34 0.001 
TAC (mmol/ml) 38.96±1.32 17.83±0.68 0.001 
Data are presented as mean±SD. Pvalues are from Student’s T-Test or Mann–Whitney U-test as 
appropriated 
 
Table 2. Pearson correlation between concentrations of different variables in diabetic patients 
and healthy subjects. 
Factors 
Glucose HbA1c (%) 
Correlation coefficient (Pvalue) Correlation coefficient (Pvalue) 
Diabetic Healthy Diabetic Healthy 
Cho (mg/dl) 0.37(0.04)  *  0.18(0.37) 0.19(0.32) -0.06(0.78) 
TG (mg/dl) 0.36(0.04)  *  -0.16(0.43) 0.21(0.26) -0.24(0.25) 
LDL-C (mg/dl) 0.32(0.08) 0.03(0.89) 0.07(0.70) -0.16(0.43) 
HDL-C (mg/dl) -0.05(0.76) 0.05(0.81) 0.06(0.75) -0.28(0.16) 
MDA (nmol/ml) 0.05(0.002) 0.4(0.03) 0.89(0.001)* 0.90(0.001)* 
TAC (mmol/ml) -0.45(0.01) -0.5(0.009) -0.88(0.001)* -0.87(0.001)* 
* Statistically significant correlation 
 
               a) Non-diabetic                                                  b) Diabetic 
                
Figure 1. Pattern of 2D-gel electrophoresis of plasma proteome in a healthy subject (a) and a diabetic patient (b) 
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                                          Healthy   
                                          Diabetic 
Figure 2. A reprehensive image showing plasma protein pattern of a healthy subjects and a diabetic patient. Spot analysis and density assay was performed using IMage master  
 
Table 3. Optical density of some spots on plasma proteome pattern that were different between 
diabetic and healthy subjects. 
Protein spots Protein Healthy Diabetic Change 
1529 Apo A1 0.770 1.071 increase 
1550 Hp α2 chain 0.510 0.362 decrease 
1573 Retinol binding protein 0.030 0.520 increase 
1294 Unidentified 0.180 0.009 decrease 
1469 Ig G light chain 0.871 0.007 decrease 
1574 Transthyretin 0.079 0.004 decrease 
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                                            A(1529)                                                                                                      B(1550) 
Figure 3. The Image view and 3D view showing different relative density of two spots in a diabetic and non-diabetic subject. A 1529 and B 1550; the first one showed 
higher and the second one lower density in diabetic patient comparing with a healthy subject 
Discussion 
Proteomic technology has a reliable method for research on 
diabetes disease-related markers, which could be used in early 
diagnosis and course confirmation. These plasma molecular 
markers, mainly low-abundance proteins, are closely related to 
the disease and promising in diagnosis, accounting for less than 
1% of plasma total protein.20 It is difficult to separate and 
characterize these proteins; since they are usually covered or 
interfered with by albumin and immunoglobulin which account 
for 70% of serum total proteins. Therefore, it is very important 
to select highly sensitive and reliable proteomic technology 
when doing plasma proteomic analysis. In this research, we 
used 2D electrophoresis. The main purpose of this study was to 
investigate the Plasma protein pattern of type 2 diabetic 
patients and compare it with those of healthy persons. To study 
the human proteome, it is possible to examine and analyze the 
proteins from different tissues such as the liver, kidneys, and 
various cancer tumors, such as breast and intestinal tumors. 
However, access to each of these tissues requires surgery, 
which is costly and dangerous and it can cause many problems 
for the patients.21 Therefore, the Plasma sample, which 
originates from all organs and tissues and is taken through 
blood vessels, is very easy and inexpensive and does not pose a 
risk to the patient. It is also repeatable when necessary, which 
is extremely important.21 Commercial diagnostic methods used 
to diagnose diseases are mostly based on ELISA systems 
(enzyme-dependent fuel safety measurements) that control the 
presence of specific protein markers in body fluids. In most 
cases, the invention of these methods has been linked to the 
accidental discovery of proteins. Protein expression changes 
significantly during disease, rather than relying on the 
simultaneous presence of proteins, by comparing protein 
expression patterns in the Plasma sample of patients and 
healthy, two-dimensional electrophoresis is used, which can be 
used to diagnose, prevent, and treat diabetes.21 
Jantos-Siwy J et al. investigated urinary biomarkers for 
diabetes, diabetic nephropathy, and non-diabetic renal 
proteinuria.22 As a result, this study suggests that the analysis 
of urinary proteomes may contribute to the early diagnosis of 
diabetic nephropathy and may provide predictive information.22 
As such, a previous study by Lopez et.al and other researchers 
indicate that almost no markers alone are enough to predict 
most diseases, and studies emphasize the need for more than 
one marker. Simultaneous analysis of several biomarkers, using 
Plasma or serum samples, can be performed by examining the 
proteome pattern. That's why this type of analysis has attracted 
a lot of attention.11 When oxidative stress increases, certain 
proteins are produced in the body that has a detrimental effect 
on the pancreas and other tissues. Therefore, the pattern of 
Plasma proteome is quite different in diabetic and non-diabetic 
patients. Pier-H Hung and colleagues who used quantitative 
proteomic analysis identified new nephropathy markers in 
Plasma applied in type 2 diabetic patients.23 Proteomic analysis 
in human disease usually adopts a comparative method that is 
defined by the differentiation of proteins in different stages of 
the disease. They found that subtypes of AMPK-Beta, 
Carnitine O-palmitoyltransferase I, and 6-phosphofructokinase 
decreased in type 2 diabetes plasma, indicating that high 
current regulators could stop AMPK expression thus fatty acid 



























Kheirodin et al 
 
International Journal of Health Studies 2021;7(4)        |          28 
carnitine O-palmitoyltransferase I; also the regulation of 
glycolysis is reduced by inhibiting 6-phosphofructokinase in 
this disease.23 
Tea Sundesten et al. use SDS-PAGE and mass 
spectrometry and found different protein expressions in type 2 
diabetic patients compared with the healthy group. Significant 
differences were observed in transferrin, albumin, and retinol-
binding protein between type 2 diabetic patients and healthy 
individuals.24 In another study, the Plasma protein pattern was 
compared to premature insulin response between two groups. 
They observed lower levels of trans-thyretin in diabetic 
patients; also 9 proteins containing trans-thyretin and alpha and 
beta-hemoglobin chains were differed.24 Increased oxidative 
stress was seen in people with high levels of MDA and low 
TAC that can moderate glycosylated protein production.24 
Quantitative plasma proteomics analysis provides a valuable 
impact on type 2 diabetes research. The quantitative proteomic 
method has shown earlier reported Plasma markers of type 2 
diabetes such as apolipoprotein A-I and phycolin-3.25 Also, 
Hong P et al. suggested several indicators indicating that type 2 
diabetes may be associated with disease progression and they 
have the potential to serve as a useful tool for monitoring 
disease progression.23 These markers require further research to 
screen and treat type 2 diabetes.23 Finding a different pattern in 
diabetes can be helpful even without knowing the identity of 
the different proteins in the pattern. Even in some studies, the 
mass to charge ratio of the identified spots has been only 
reported. Identifying different points in the two-dimensional 
model even provides information that can predict whether 
diabetes is related to genetic or environmental factors. 
Diabetes mellitus is one of the most common endocrine 
diseases and one of the most widespread health problems in the 
world today.25 Appropriate strategies have been developed to 
prevent, treat, control, and reduce the disorders associated with 
this disease.26 Increased glucose releases radicals into body 
tissues, especially pancreatic cells. As a result of the imbalance 
between the production of free radicals and active oxygen 
species on the one hand, and the antioxidant defense system on 
the other, oxidative stress is produced.27 One of the aims of this 
research was to study the pattern of plasma proteome in 
patients with type 2 diabetes and their relationship with 
oxidative stress indicators. 
The results showed a significantly higher level of HbA1c 
(Pvalue<0.01) in diabetic patients compared with healthy 
subjects. This was consistent with a study by Inoue et al, that 
predicted a combined use of FPG and HbA1c levels in people 
with diabetes or at-risk individuals.28,29 The results of this study 
indicated an increase in malondialdehyde due to increased lipid 
peroxidation in diabetic patients. These results are consistent 
with the findings of other studies. Ramakrishna V et al. 
reported that increased lipid peroxidation and protein oxidation 
in type 2 diabetic patients reduced the levels of enzymatic and 
non-enzymatic antioxidants.30 However, diabetic patients are 
prone to oxidative stress. There is a link between high blood 
sugar and lipid peroxidation through free radicals production.31 
The positive correlation between FBG and malondialdehyde 
has been reported in type 1 diabetic patients.32 According to 
previous studies, the FRAP method has been used to determine 
the potency of antioxidants in Plasma, and in some of these 
studies, Plasma antioxidant levels have been reduced in 
diabetic patients. In this study, an increase in lipid 
peroxidation, and a decrease in Plasma TAC in diabetic 
patients were observed. About malondialdehyde and total 
antioxidant capacity, the findings were similar to those of 
Hisalkar, P. et al.33 They showed a decrease in reduced 
antioxidant capacity (TAC), which was more severe in patients 
with type 2 diabetes than in the control group. There was a 
significant relationship between antioxidant capacity and 
control of blood sugar.33 
In this study, serum levels of oxidative stress indicators in 
diabetic patients and non-diabetic were compared. The level of 
MDA, which was an oxidant, increased, and the level of TAC, 
which was an antioxidant, decreased (Pvalue<0.01), affecting 
the Plasma proteome pattern. 
Chronic hyperglycemia in diabetes due to the production 
and accumulation of reactive oxygen species (ROS) and 
nitrogen (RNS) radicals causes oxidative stress in body tissues, 
especially pancreatic beta cells.34 The formation of these 
radicals destroys vital large molecules of cells, peroxidation of 
membrane lipids, and finally leads to cell damage.35 
Elevated blood glucose affects oxidative stress indices. 
When antioxidant activity reduces in the body, oxidative stress 
increases, which in turn inflammatory reactions increase that 
can affect protein patterns. When intracellular glucose 
increased, advanced glycosylation end-products (AGEs) are 
produced, through non-enzymatic glycosylation of cellular 
proteins that affect the structure, function, and molecular 
weight of the protein, all of which alter the plasma proteome 
pattern. In this study, a different proteomic pattern was 
observed in the two groups of diabetic and non-diabetic. Two-
dimensional gel electrophoresis was analyzed using image 
Master software; different patterns were obtained due to 
various proteins with different concentrations. Accurate 
recognition of these proteins required more advanced assays.  
The results of our study showed that lipid peroxidation 
increased in diabetes while total oxidant capacity decreased 
significantly. Some changes in Plasma proteome can be the 
result of the glycation process that occurs on proteins in 
diabetes. The human Plasma proteome promises to 
revolutionize disease diagnosis and surveillance. Some changes 
in Plasma protein that were found in this study can be 
considered as possible or putative biomarkers in type 2 
diabetes. The exact identification of these proteins needs a 
MALTI-TOF analysis.   
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